ILUVIEN patient case study library Phakic Eye Treatment Burden Managing IOP Vitrectomized Case 3 years of Iluvien Treatment Burden “I wanted a treatment that was designed to treat patients for a longer time. When your patients ask, answer and act.” — Jessica D. McCluskey, MD Results presented below are from a single case; results may vary. Jessica D. McCluskey, MD Board-certified ophthalmologist and fellowship-trained retina specialist at Thomas Eye Group, a large multispecialty ophthalmology practice. Academic affiliations: Medical School at the University of Mississippi – received Awards in Excellence in the fields of ophthalmology and neurosurgery Four-year ophthalmology residency at the University of Mississippi where she served as chief resident Two-year retina fellowship at the University of Texas Southwestern Medical Center Patient profile1 Sex: Female Age: 73 Diagnosis: DME Treated eye: OS Concomitant conditions: • High blood pressure • Hypercholesterolemia • Proliferative diabetic retinopathy with 2 panretinal photocoagulations Treatment history: • 2X Focal laser • 8X Anti-VEGF • 6X Corticosteroid Notes: Pseudophakic Reasons Dr. McCluskey chose ILUVIEN: Patient history of monthly injections over the course of 6 years Missed injections negatively impacted patient’s vision Interested in an alternative to monthly injections Patient outcome Vision was maintained over 1 year of follow-up Good CST reduction and maintenance IOP stable No further treatment was needed during the 15-month follow-up period “This patient received monthly DME injections for years and after the ILUVIEN injection, she has not had another injection in 16 months. That’s a huge success for my patient.” — Jessica D. McCluskey, MD Retinal thickness (μm) Best corrected visual acuity (BCVA) Intraocular pressure (IOP) Selected OCT Scans Baseline ILUVIEN injected Visual Acuity: 20/40 Letters: 70 OCT: 485 μm IOP: 14 mm Hg After treatment with ILUVIEN 1 month after Visual Acuity: 20/30 Letters: 76 OCT: 291 um IOP: 16 mm HG 1/4 8 months after Visual Acuity: 20/40 Letters: 70 OCT: 311 um IOP: 15 mm HG 2/4 12 months after Visual Acuity: 20/30 Letters: 76 OCT: 284 um IOP: 14 mm HG 3/4 15 months after Visual Acuity: 20/25 Letters: 80 OCT: 262 um IOP: 15 mm HG 4/4 TREATMENTBURDEN CASEDownload a printable, pdf version of this case. Download CaseTREATMENTBURDEN DATASee how ILUVIEN reduced treatment burden in the real-world USER Study. LEARN MORE